A vaccine for tularaemia.

doi:10.1517/14712598.3.4.645

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

A vaccine for tularaemia.

Expert opinion on biological therapy - 1 Jul 2003

Titball R W, Oyston P C F

Abstract excerpt

Francisella tularensis is an intracellular pathogen with a very low infectious dose for humans. Several forms of tularaemia occur, which range from a severely debilitating to a fatal disease. Diagnosis is difficult due to the generalised, nonspecific nature of symptoms and the difficulty in culturing the slow-growing and nutritionally fastidious pathogen. A live attenuated vaccine strain (LVS) has been used in...

Topics

Animals
Bacterial Vaccines
Francisella tularensis
Humans
Mutation
Tularemia
Vaccines, Attenuated

Source

Open in PubMed

Identifiers

PMID: 12831369
DOI: 10.1517/14712598.3.4.645

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics